Therapeutic potential of mesenchymal stem cells in regenerative medicine

Stem Cells International

Volumn , Issue , 2013, Pages

  Patel, Devang M ^a   Shah, Jainy ^a   Srivastava, Anand S ^b  

^a GIOSTAR Saviour Hospital   (India)

^b Global Institute of Stem Cell Therapy and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; LYMPHOCYTE SURFACE MARKER; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; BONE DISEASE; CELL HOMING; CELL MIGRATION; CELL POPULATION; CHONDROGENESIS; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DIABETES MELLITUS; ECTODERM; ENDODERM; HEART DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; KIDNEY DISEASE; LIVER DISEASE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESODERM; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE REPAIR;

EID: 84876536833     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/496218     Document Type: Review

References (183)

1. Graf T., Differentiation plasticity of hematopoietic cells. Blood 2002 99 9 3089 3101 2-s2.0-0036566226 10.1182/blood.V99.9.3089 (Pubitemid 34525285)
2. Watt F. M., Hogan B. L. M., Out of eden: stem cells and their niches. Science 2000 287 5457 1427 1430 2-s2.0-0034712109 10.1126/science.287.5457.1427 (Pubitemid 30127126)
3. Porada C. D., Zanjani E. D., Almeida-Porad G., Adult mesenchymal stem cells: a pluripotent population with multiple applications. Current stem cell research & therapy 2006 1 3 365 369 2-s2.0-37749044815
4. da Silva Meirelles L., Chagastelles P. C., Nardi N. B., Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science 2006 119 11 2204 2213 2-s2.0-33745503987 10.1242/jcs.02932 (Pubitemid 43960310)
5. Parekkadan B., Milwid J. M., Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering 2010 12 87 117 2-s2.0-77955617561 10.1146/annurev-bioeng-070909-105309
6. Friedenstein A. J., Gorskaja U. F., Kulagina N. N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380
7. Owen M., Friedenstein A. J., Stromal stem cells: marrow-derived osteogenic precursors. Ciba Foundation symposium 1988 136 42 60 2-s2.0-0024252149
8. Owen M., Marrow stromal stem cells. Journal of Cell Science 1988 10 63 76 2-s2.0-0024147344 (Pubitemid 19096575)
9. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
10. Caplan A. I., Mesenchymal stem cells. Journal of Orthopaedic Research 1991 9 5 641 650 2-s2.0-0026228558
11. Lazarus H. M., Haynesworth S. E., Gerson S. L., Rosenthal N. S., Caplan A. I., Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplantation 1995 16 4 557 564 2-s2.0-0028881201
12. Motaln H., Schichor C., Lah T. T., Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010 116 11 2519 2530 2-s2.0-77952805220 10.1002/cncr.25056
13. Chamberlain G., Fox J., Ashton B., Middleton J., Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007 25 11 2739 2749 2-s2.0-36248932643 10.1634/stemcells.2007-0197 (Pubitemid 350127858)
14. Planat-Benard V., Silvestre J. S., Cousin B., André M., Nibbelink M., Tamarat R., Clergue M., Manneville C., Saillan-Barreau C., Duriez M., Tedgui A., Levy B., Pénicaud L., Casteilla L., Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004 109 5 656 663 2-s2.0-10744222119 10.1161/01.CIR.0000114522.38265.61 (Pubitemid 38198874)
15. Battula V. L., Treml S., Bareiss P. M., Gieseke F., Roelofs H., De Zwart P., Müller I., Schewe B., Skutella T., Fibbe W. E., Kanz L., Bühring H. J., Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009 94 2 173 184 2-s2.0-59449093151 10.3324/haematol.13740
16. Sivasubramaniyan K., Lehnen D., Ghazanfari R., Sobiesiak M., Harichandan A., Mortha E., Petkova N., Grimm S., Cerabona F., de Zwart P., Abele H., Aicher W. K., Faul C., Kanz L., Buhring H. J., Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Annals of the New York Academy of Sciences 2012 1266 94 106 10.1111/j.1749-6632.2012.06551.x
17. Ding D. C., Shyu W. C., Lin S. Z., Mesenchymal stem cells. Cell Transplantation 2011 20 1 5 14 2-s2.0-79952491643 10.3727/096368910X
18. Hwang N. S., Zhang C., Hwang Y. S., Varghese S., Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdisciplinary Reviews 2009 1 1 97 106 2-s2.0-79952110739 10.1002/wsbm.26
19. Teven C. M., Liu X., Hu N., Tang N., Kim S. H., Huang E., Yang K., Li M., Gao J. L., Liu H., Natale R. B., Luther G., Luo Q., Wang L., Rames R., Bi Y., Luo J., Luu H. H., Haydon R. C., Reid R. R., He T. C., Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells International 2011 2011 18 201371 10.4061/2011/201371
20. Deng Z. L., Sharff K. A., Tang N., Song W. X., Luo J., Luo X., Chen J., Bennett E., Reid R., Manning D., Xue A., Montag A. G., Luu H. H., Haydon R. C., He T. C., Regulation of osteogenic differentiation during skeletal development. Frontiers in Bioscience 2008 13 6 2001 2021 2-s2.0-38449093315 10.2741/2819 (Pubitemid 351589231)
21. Baker N., Zhang G., You Y., Tuan R. S., Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. Journal of Cellular Biochemistry 2012 113 12 3773 3787 10.1002/jcb.24252
22. Xu D. J., Zhao Y. Z., Wang J., He J. W., Weng Y. G., Luo J. Y., Smads p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Reports 2012 45 4 247 252 10.5483/BMBRep.2012.45.4. 247
23. Zheng H., Guo Z., Ma Q., Jia H., Dang G., Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcified Tissue International 2004 74 2 194 203 2-s2.0-1342323579 10.1007/s00223-003- 0004-x (Pubitemid 38263863)
24. Gaur T., Lengner C. J., Hovhannisyan H., Bhat R. A., Bodine P. V. N., Komm B. S., Javed A., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. Journal of Biological Chemistry 2005 280 39 33132 33140 2-s2.0-25844509347 10.1074/jbc.M500608200 (Pubitemid 41397109)
25. Alm J. J., Heino T. J., Hentunen T. A., Vaananen H. K., Aro H. T., Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells. Tissue Engineering C 2012 18 9 658 666 10.1089/ten.tec.2011.0675
26. Cameron K., Travers P., Chander C., Buckland T., Campion C., Noble B., Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate. Journal of Biomedical Materials Research A 2013 101 1 13 22
27. Tang Z., Shi D., Jia B., Chen J., Zong C., Shen D., Zheng Q., Wang J., Tong X., Exchange protein activated by cyclic adenosine monophosphate regulates the switch between adipogenesis and osteogenesis of human mesenchymal stem cells through increasing the activation of phosphatidylinositol 3-kinase. The International Journal of Biochemistry & Cell Biology 2012 44 7 1106 1120 10.1016/j.biocel.2012.03.019
28. Huang C. Y. C., Hagar K. L., Frost L. E., Sun Y., Cheung H. S., Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 2004 22 3 313 323 2-s2.0-2942553906 (Pubitemid 38736615)
29. Paik S., Jung H. S., Lee S., Yoon D. S., Park M. S., Lee J. W., miR-449a regulates the chondrogenesis of human mesenchymal stem cells through direct targeting of lymphoid enhancer-binding factor-1. Stem Cells and Development 2012 21 18 3298 3308 10.1089/scd.2011.0732
30. Day T. F., Guo X., Garrett-Beal L., Yang Y., Wnt/ β -catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Developmental Cell 2005 8 5 739 750 2-s2.0-17844372752 10.1016/j.devcel.2005.03.016 (Pubitemid 40585296)
31. Cheng T., Yang C., Weber N., Kim H. T., Kuo A. C., Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis. Biochemical and Biophysical Research Communications 2012 426 4 544 550 10.1016/j.bbrc.2012.08.124
32. Yanjie J., Jiping S., Yan Z., Xiaofeng Z., Boai Z., Yajun L., Effects of Notch-1 signalling pathway on differentiation of marrow mesenchymal stem cells into neurons in vitro. NeuroReport 2007 18 14 1443 1447 2-s2.0-34548092682 10.1097/WNR.0b013e3282ef7753 (Pubitemid 47295942)
33. Wang S., Kan Q., Sun Y., Han R., Zhang G., Peng T., Jia Y., Caveolin-1 regulates neural differentiation of rat bone mesenchymal stem cells into neurons by modulating notch signaling. International Journal of Developmental Neuroscience 2012 31 1 30 35 10.1016/j.ijdevneu.2012.09.004
34. Lee K. D., Kuo T. K. C., Whang-Peng J., Chung Y. F., Lin C. T., Chou S. H., Chen J. R., Chen Y. P., Lee O. K. S., In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004 40 6 1275 1284 2-s2.0-10644283018 10.1002/hep.20469 (Pubitemid 39657001)
35. Chen L. B., Jiang X. B., Yang L., Differentiation of rat marrow mesenchymal stem cells into pancreatic islet β -cells. World Journal of Gastroenterology 2004 10 20 3016 3020 2-s2.0-4644310257 (Pubitemid 39303055)
36. Bhandari D. R., Seo K. W., Roh K. H., Jung J. W., Kang S. K., Kang K. S., REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem Cells. PLoS ONE 2010 5 5 2-s2.0-77956293210 e10493
37. Chandra V., G S., Phadnis S., Nair P. D., Bhonde R. R., Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 2009 27 8 1941 1953 2-s2.0-69249196200 10.1002/stem.117
38. Ray P., De A., Min J. J., Tsien R. Y., Gambhir S. S., Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Research 2004 64 4 1323 1330 2-s2.0-1242338786 10.1158/0008-5472.CAN-03-1816 (Pubitemid 38235600)
39. Brazelton T. R., Blau H. M., Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 2005 23 9 1251 1265 2-s2.0-27144521149 10.1634/stemcells.2005-0149 (Pubitemid 41504913)
40. Otto W. R., Wright N. A., Mesenchymal stem cells: from experiment to clinic. Fibrogenesis & Tissue Repair 2011 4 20 10.1186/1755-1536-4-20
41. Granero-Molto F., Weis J. A., Longobardi L., Spagnoli A., Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opinion on Biological Therapy 2008 8 3 255 268 2-s2.0-41149119151 10.1517/14712598.8.3.255 (Pubitemid 351428415)
42. Hiasa K. I., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1 α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004 109 20 2454 2461 2-s2.0-2542464782 10.1161/01.CIR.0000128213. 96779.61 (Pubitemid 38679567)
43. Ma J., Ge J., Zhang S., Sun A., Shen J., Chen L., Wang K., Zou Y., Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Research in Cardiology 2005 100 3 217 223 2-s2.0-25144491290 10.1007/s00395-005-0521-z (Pubitemid 41348812)
44. Ip J. E., Wu Y., Huang J., Zhang L., Pratt R. E., Dzau V. J., Mesenchymal stem cells use integrin β 1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Molecular Biology of the Cell 2007 18 8 2873 2882 2-s2.0-34547740001 10.1091/mbc.E07-02-0166 (Pubitemid 47235295)
45. Hou X., Wu X., Ma J., Lv X., Jin X., Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia. Molecular Biology Reports 2010 37 3 1467 1475 2-s2.0-77951884438 10.1007/s11033-009-9541-3
46. Badri L., Lama V. N., Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the β -catenin pathway. Stem Cells 2012 30 9 2010 2019 10.1002/stem.1171
47. Freytes D. O., Kang J. W., Marcos-Campos I., Vunjak-Novakovic G., Macrophages modulate the viability and growth of human mesenchymal stem cells. Journal of Cellular Biochemistry 2013 114 1 220 229 10.1002/jcb.24357
48. Rüster B., Göttig S., Ludwig R. J., Bistrian R., Müller S., Seifried E., Gille J., Henschler R., Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006 108 12 3938 3944 2-s2.0-33845277598 10.1182/blood-2006-05-025098 (Pubitemid 44864580)
49. Mirza A., Hyvelin J. M., Rochefort G. Y., Lermusiaux P., Antier D., Awede B., Bonnet P., Domenech J., Eder V., Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. Journal of Vascular Surgery 2008 47 6 1313 1321 2-s2.0-44349090551 10.1016/j.jvs.2007.12.038
50. Sheng Z., Fu X., Cai S., Lei Y., Sun T., Bai X., Chen M., Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells. Wound Repair and Regeneration 2009 17 3 427 435 2-s2.0-65949095665 10.1111/j.1524-475X.2009.00474.x
51. Aronin C. E. P., Tuan R. S., Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Research C 2010 90 1 67 74 2-s2.0-77949691535 10.1002/bdrc.20174
52. Li Y., Chen J., Chen X. G., Wang L., Gautam S. C., Xu Y. X., Katakowski M., Zhang L. J., Lu M., Janakiraman N., Chopp M., Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002 59 4 514 523 2-s2.0-0037183512 (Pubitemid 34919983)
53. Askari A. T., Unzek S., Popovic Z. B., Goldman C. K., Forudi F., Kiedrowski M., Rovner A., Ellis S. G., Thomas J. D., DiCorleto P. E., Topol E. J., Penn M. S., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. The Lancet 2003 362 9385 697 703 2-s2.0-0041327804 10.1016/S0140-6736(03)14232-8 (Pubitemid 37101067)
54. Nicola M. D., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., Gianni A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 10 3838 3843 2-s2.0-0037093058 10.1182/blood.V99.10.3838 (Pubitemid 34534559)
55. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology 2002 30 1 42 48 2-s2.0-0036142769 10.1016/S0301-472X(01)00769-X (Pubitemid 34059216)
56. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., Jorgensen C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 10 3837 3844 2-s2.0-0242410394 10.1182/blood-2003-04-1193 (Pubitemid 37409409)
57. Djouad F., Charbonnier L. M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., Cantos C., Jorgensen C., Noël D., Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6- dependent mechanism. Stem Cells 2007 25 8 2025 2032 2-s2.0-34547903606 10.1634/stemcells.2006-0548 (Pubitemid 47258180)
58. Glennie S., Soeiro I., Dyson P. J., Lam E. W. F., Dazzi F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 105 7 2821 2827 2-s2.0-15944376184 10.1182/blood-2004-09-3696 (Pubitemid 40446275)
59. Sotiropoulou P. A., Perez S. A., Gritzapis A. D., Baxevanis C. N., Papamichail M., Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006 24 1 74 85 2-s2.0-33645508766 10.1634/stemcells. 2004-0359
60. Spaggiari G. M., Capobianco A., Becchetti S., Mingari M. C., Moretta L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006 107 4 1484 1490 2-s2.0-32644438233 10.1182/blood-2005-07-2775 (Pubitemid 43242385)
61. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet 2004 363 9419 1439 1441 2-s2.0-2342482526 10.1016/S0140-6736(04)16104-7 (Pubitemid 38586721)
62. Zheng Z. H., Li X. Y., Ding J., Jia J. F., Zhu P., Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology 2008 47 1 22 30 2-s2.0-37349104020 10.1093/rheumatology/kem284 (Pubitemid 350286256)
63. Dazzi F., Krampera M., Mesenchymal stem cells and autoimmune diseases. Best Practice and Research 2011 24 1 49 57 2-s2.0-79952600397 10.1016/j.beha.2011.01.002
64. Yi T., Song S. U., Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Archives of Pharmacal Research 2012 35 2 213 221 10.1007/s12272-012-0202-z
65. Joo Y. O., Mee K. K., Mi S. S., Hyun J. L., Jung H. K., Won R. W., Jin H. L., The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008 26 4 1047 1055 2-s2.0-49249129381 10.1634/stemcells.2007-0737
66. Groh M. E., Maitra B., Szekely E., Koç O. N., Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Experimental Hematology 2005 33 8 928 934 2-s2.0-22144473736 10.1016/j.exphem.2005.05.002 (Pubitemid 40982660)
67. Jones S., Horwood N., Cope A., Dazzi F., The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. Journal of Immunology 2007 179 5 2824 2831 2-s2.0-38449121250
68. De Miguel M. P., Fuentes-Julian S., Blazquez-Martinez A., Pascual C. Y., Aller M. A., Arias J., Arnalich-Montiel F., Immunosuppressive properties of mesenchymal stem cells: advances and applications. Current Molecular Medicine 2012 12 5 574 591 10.2174/156652412800619950
69. Li W., Ren G., Huang Y., Su J., Han Y., Li J., Chen X., Cao K., Chen Q., Shou P., Zhang L., Yuan Z. R., Roberts A. I., Shi S., Le A. D., Shi Y., Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death and Differentiation 2012 19 1505 1513 10.1038/cdd.2012.26
70. Mishra P. K., Singh S. R., Joshua I. G., Tyagi S. C., Stem cells as a therapeutic target for diabetes. Frontiers in Bioscience 2010 15 2 461 477 2-s2.0-77951222267 10.2741/3630
71. Volarevic V., Arsenijevic N., Lukic M. L., Stojkovic M., Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 2011 29 1 5 10 2-s2.0-79951834186 10.1002/stem.556
72. Sun Y., Chen L., Hou X. G., Hou W. K., Dong J. J., Sun L., Tang K. X., Wang B., Song J., Li H., Wang K. X., Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal 2007 120 9 771 776 2-s2.0-34248652441 (Pubitemid 46767823)
73. Chao K. C., Chao K. F., Fu Y. S., Liu S. H., Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE 2008 3 1 2-s2.0-39049164672 10.1371/journal.pone.0001451 e1451 (Pubitemid 351248247)
74. Cancelas J. A., Williams D. A., Stem cell mobilization by β 2-agonists. Nature Medicine 2006 12 3 278 279 2-s2.0-33644832287 10.1038/nm0306-278 (Pubitemid 43355070)
75. Guo Q. S., Zhu M. Y., Wang L., Fan X. J., Lu Y. H., Wang Z. W., Zhu S. J., Wang Y., Huang Y., Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells. Experimental Diabetes Research 2012 2012 10 672013 10.1155/2012/672013
76. Li H. T., Jiang F. X., Shi P., Zhang T., Liu X. Y., Lin X. W., Pang X. N., In vitro reprogramming of rat bone marrow-derived mesenchymal stem cells into insulin-producing cells by genetically manipulating negative and positive regulators. Biochemical and Biophysical Research Communications 2012 420 4 793 798 10.1016/j.bbrc.2012.03.076
77. Timper K., Seboek D., Eberhardt M., Linscheid P., Christ-Crain M., Keller U., Müller B., Zulewski H., Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochemical and Biophysical Research Communications 2006 341 4 1135 1140 2-s2.0-32344451060 10.1016/j.bbrc.2006.01.072 (Pubitemid 43221783)
78. Ezquer F., Ezquer M., Contador D., Ricca M., Simon V., Conget P., The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells 2012 30 8 1664 1674 10.1002/stem.1132
79. Ho J. H., Tseng T. C., Ma W. H., Ong W. K., Chen Y. F., Chen M. H., Lin M. W., Hong C. Y., Lee O. K., Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and beta-cell differentiation in streptozocin-induced diabetic mice. Cell Transplantation 2012 21 1 217 234 10.3727/096368911X603611
80. Si Y., Zhao Y., Hao H., Liu J., Guo Y., Mu Y., Shen J., Cheng Y., Fu X., Han W., Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes 2012 61 6 1616 1625 10.2337/db11-1141
81. Jiang R., Han Z., Zhuo G., Qu X., Li X., Wang X., Shao Y., Yang S., Han Z. C., Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Frontiers of Medicine 2011 5 1 94 100 10.1007/s11684-011-0116-z
82. Yu M., Zhou W., Song Y., Yu F., Li D., Na S., Zou G., Zhai M., Xie C., Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model. Bone 2011 49 3 387 394 2-s2.0-79960603949 10.1016/j.bone.2011.05.025
83. Bhansali A., Upreti V., Khandelwal N., Marwaha N., Gupta V., Sachdeva N., Sharma R. R., Saluja K., Dutta P., Walia R., Minz R., Bhadada S., Das S., Ramakrishnan S., Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells and Development 2009 18 10 1407 1415 2-s2.0-72849135096 10.1089/scd.2009.0164
84. Camp T. M., Tyagi S. C., Senior R. M., Hayden M. R., Tyagi S. C., Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia 2003 46 10 1438 1445 2-s2.0-0142061935 10.1007/s00125-003-1200-y (Pubitemid 37297215)
85. Yoon Y. S., Uchida S., Masuo O., Cejna M., Park J. S., Gwon H. C., Kirchmair R., Bahlman F., Walter D., Curry C., Hanley A., Isner J. M., Losordo D. W., Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005 111 16 2073 2085 2-s2.0-20244378531 10.1161/01.CIR.0000162472. 52990.36 (Pubitemid 40577902)
86. Zhang N., Li J., Luo R., Jiang J., Wang J. A., Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Experimental and Clinical Endocrinology and Diabetes 2008 116 2 104 111 2-s2.0-40549118860 10.1055/s-2007-985154 (Pubitemid 351363380)
87. Herrera M. B., Bussolati B., Bruno S., Fonsato V., Romanazzi G. M., Camussi G., Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. International journal of molecular medicine 2004 14 6 1035 1041 2-s2.0-19544364818
88. Ezquer F., Ezquer M., Simon V., Pardo F., Yañez A., Carpio D., Conget P., Endovenous administration of bone marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biology of Blood and Marrow Transplantation 2009 15 11 1354 1365 2-s2.0-70350603058 10.1016/j.bbmt.2009.07.022
89. Lee R. H., Seo M. J., Reger R. L., Spees J. L., Pulin A. A., Olson S. D., Prockop D. J., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17438 17443 2-s2.0-33751232671 10.1073/pnas.0608249103 (Pubitemid 44788987)
90. Shibata T., Naruse K., Kamiya H., Kozakae M., Kondo M., Yasuda Y., Nakamura N., Ota K., Tosaki T., Matsuki T., Nakashima E., Hamada Y., Oiso Y., Nakamura J., Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 2008 57 11 3099 3107 2-s2.0-58149337284 10.2337/db08-0031
91. Kwon D. S., Gao X., Liu Y. B., Dulchavsky D. S., Danyluk A. L., Bansal M., Chopp M., McIntosh K., Arbab A. S., Dulchavsky S. A., Gautam S. C., Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. International Wound Journal 2008 5 3 453 463 2-s2.0-45749110910 10.1111/j.1742-481X.2007.00408.x (Pubitemid 351874520)
92. Williams A. R., Hare J. M., Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research 2011 109 923 940 10.1161/CIRCRESAHA.111. 243147
93. Cashman T. J., Gouon-Evans V., Costa K. D., Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms. Stem Cell Reviews. In press
94. Shake J. G., Gruber P. J., Baumgartner W. A., Senechal G., Meyers J., Redmond J. M., Pittenger M. F., Martin B. J., Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Annals of Thoracic Surgery 2002 73 6 1919 1926 2-s2.0-0036266426 10.1016/S0003- 4975(02)03517-8 (Pubitemid 34596742)
95. Toma C., Pittenger M. F., Cahill K. S., Byrne B. J., Kessler P. D., Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002 105 1 93 98 2-s2.0-0036142213 10.1161/hc0102.101442 (Pubitemid 34049148)
96. Quevedo H. C., Hatzistergos K. E., Oskouei B. N., Feigenbaum G. S., Rodriguez J. E., Valdes D., Pattany P. M., Zambrano J. P., Hu Q., McNiece I., Heldman A. W., Hare J. M., Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 14022 14027 2-s2.0-69549138471 10.1073/pnas.0903201106
97. Makkar R. R., Price M. J., Lill M., Frantzen M., Takizawa K., Kleisli T., Zheng J., Kar S., McClelan R., Miyamota T., Bick-Forrester J., Fishbein M. C., Shah P. K., Forrester J. S., Sharifi B., Chen P. S., Qayyum M., Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. Journal of Cardiovascular Pharmacology and Therapeutics 2005 10 4 225 233 2-s2.0-29344465127 10.1177/107424840501000403 (Pubitemid 43003333)
98. Silva G. V., Litovsky S., Assad J. A. R., Sousa A. L. S., Martin B. J., Vela D., Coulter S. C., Lin J., Ober J., Vaughn W. K., Branco R. V. C., Oliveira E. M., He R., Geng Y. J., Willerson J. T., Perin E. C., Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005 111 2 150 156 2-s2.0-19944432052 10.1161/01.CIR.0000151812.86142.45 (Pubitemid 40139725)
99. Yang Y. J., Qian H. Y., Huang J., Li J. J., Gao R. L., Dou K. F., Yang G. S., Willerson J. T., Geng Y. J., Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 12 2076 2082 2-s2.0-73849116441 10.1161/ATVBAHA.109.189662
100. Dixon J. A., Gorman R. C., Stroud R. E., Bouges S., Hirotsugu H., Gorman J. H., Martens T. P., Itescu S., Schuster M. D., Plappert T., St John-Sutton M. G., Spinale F. G., Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 2009 120 1 S220 S229 2-s2.0-70349785585 10.1161/CIRCULATIONAHA.108.842302
101. Chen S. L., Fang W. W., Ye F., Liu Y. H., Qian J., Shan S. J., Zhang J. J., Chunhua R. Z., Liao L. M., Lin S., Sun J. P., Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. American Journal of Cardiology 2004 94 1 92 95 2-s2.0-3042662157 10.1016/j.amjcard.2004.03.034 (Pubitemid 38813459)
102. Hare J. M., Traverse J. H., Henry T. D., Dib N., Strumpf R. K., Schulman S. P., Gerstenblith G., DeMaria A. N., Denktas A. E., Gammon R. S., Hermiller J. B., Reisman M. A., Schaer G. L., Sherman W., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology 2009 54 24 2277 2286 2-s2.0-70549103270 10.1016/j.jacc.2009.06.055
103. Williams A. R., Trachtenberg B., Velazquez D. L., McNiece I., Altman P., Rouy D., Mendizabal A. M., Pattany P. M., Lopera G. A., Fishman J., Zambrano J. P., Heldman A. W., Hare J. M., Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circulation Research 2011 108 792 796 10.1161/CIRCRESAHA.111.242610
104. Chachques J. C., Trainini J. C., Lago N., Masoli O. H., Barisani J. L., Cortes-Morichetti M., Schussler O., Carpentier A., Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplantation 2007 16 9 927 934 2-s2.0-41249095895 10.3727/096368907783338217 (Pubitemid 351448610)
105. Chachques J. C., Trainini J. C., Lago N., Cortes-Morichetti M., Schussler O., Carpentier A., Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Annals of Thoracic Surgery 2008 85 3 901 908 2-s2.0-39349108880 10.1016/j.athoracsur.2007. 10.052 (Pubitemid 351260021)
106. Shabbir A., Zisa D., Lin H., Mastri M., Roloff G., Suzuki G., Lee T., Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. American Journal of Physiology 2010 299 5 H1428 H1438 2-s2.0-78249278186 10.1152/ajpheart.00488.2010
107. DeSantiago J., Bare D. J., Semenov I., Minshall R. D., Geenen D. L., Wolska B. M., Banach K., Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cells. Journal of Molecular and Cellular Cardiology 2012 52 6 1249 1256 10.1016/j.yjmcc.2012.03. 008
108. Stock P., Brückner S., Ebensing S., Hempel M., Dollinger M. M., Christ B., The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nature Protocols 2010 5 4 617 627 2-s2.0-77949457175 10.1038/nprot.2010.7
109. Sato Y., Araki H., Kato J., Nakamura K., Kawano Y., Kobune M., Sato T., Miyanishi K., Takayama T., Takahashi M., Takimoto R., Iyama S., Matsunaga T., Ohtani S., Matsuura A., Hamada H., Niitsu Y., Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005 106 2 756 763 2-s2.0-22144460191 10.1182/blood-2005- 02-0572 (Pubitemid 40981278)
110. Chang Y. J., Liu J. W., Lin P. C., Sun L. Y., Peng C. W., Luo G. H., Chen T. M., Lee R. P., Lin S. Z., Harn H. J., Chiou T. W., Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sciences 2009 85 13-14 517 525 2-s2.0-70249138772 10.1016/j.lfs.2009.08.003
111. Hwang S., Hong H. N., Kim H. S., Park S. R., Won Y. J., Choi S. T., Choi D., Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biology International 2011 36 3 279 288 10.1042/CBI20110325
112. Zhao D. C., Lei J. X., Chen R., Yu W. H., Zhang X. M., Li S. N., Xiang P., Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World Journal of Gastroenterology 2005 11 22 3431 3440 2-s2.0-21044434501 (Pubitemid 40873250)
113. Abdel Aziz M. T., Atta H. M., Mahfouz S., Fouad H. H., Roshdy N. K., Ahmed H. H., Rashed L. A., Sabry D., Hassouna A. A., Hasan N. M., Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clinical Biochemistry 2007 40 12 893 899 2-s2.0-34447558272 10.1016/j.clinbiochem.2007.04.017 (Pubitemid 47082440)
114. Tsai P. C., Fu T. W., Chen Y. M. A., Ko T. L., Chen T. H., Shih Y. H.,
115. Kuo T. K., Hung S. P., Chuang C. H., Chen C. T., Shih Y. V., Fang S. Y., Yang V. W., Lee O. K., Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008 134 7 2111 2121.e3 2-s2.0-44649136845 10.1053/j.gastro.2008.03.015 (Pubitemid 351783270)
116. Burra P., Arcidiacono D., Bizzaro D., Chioato T., Di Liddo R., Banerjee A., Cappon A., Bo P., Conconi M. T., Parnigotto P. P., Mirandola S., Gringeri E., Carraro A., Cillo U., Russo F. P., Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. BMC Gastroenterology 2012 12 88 10.1186/1471-230X-12-88
117. Xu H., Qian H., Zhu W., Zhang X., Yan Y., Mao F., Wang M., Xu H., Xu W., Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum -induced mouse liver injury. Experimental Biology and Medicine 2012 237 5 585 592 10.1258/ebm.2012.011362
118. Cho K. A., Woo S. Y., Seoh J. Y., Han H. S., Ryu K. H., Mesenchymal stem cells restore CCl4-induced liver injury by an antioxidative process. Cell Biology International 2012 36 1267 1274 10.1042/CBI20110634
119. Aldridge V., Garg A., Davies N., Bartlett D. C., Youster J., Beard H., Kavanagh D. P., Kalia N., Frampton J., Lalor P. F., Newsome P. N., Human mesenchymal stem cells are recruited to injured liver in a β 1-integrin and CD44 dependent manner. Hepatology 2012 56 1063 1073
120. Cao H., Yang J., Yu J., Pan Q., Li J., Zhou P., Li Y., Pan X., Li J., Wang Y., Li L., Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Medicine 2012 10 56 10.1186/1741-7015-10-56
121. Zhao W., Li J. J., Cao D. Y., Li X., Zhang L. Y., He Y., Yue S. Q., Wang D. S., Dou K. F., Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World Journal of Gastroenterology 2012 18 1048 1058 10.3748/wjg.v18.i10.1048
122. El Ansary M., Abdel-Aziz I., Mogawer S., Abdel-Hamid S., Hammam O., Teaema S., Wahdan M., Phase II Trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rreviews 2012 8 3 972 981 10.1007/s12015-011-9322-y
123. Kharaziha P., Hellström P. M., Noorinayer B., Farzaneh F., Aghajani K., Jafari F., Telkabadi M., Atashi A., Honardoost M., Zali M. R., Soleimani M., Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. European Journal of Gastroenterology and Hepatology 2009 21 10 1199 1205 2-s2.0-70349733505 10.1097/MEG.0b013e32832a1f6c
124. Mohamadnejad M., Alimoghaddam K., Mohyeddin-Bonab M., Bagheri M., Bashtar M., Ghanaati H., Baharvand H., Ghavamzadeh A., Malekzadeh R., Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Archives of Iranian Medicine 2007 10 4 459 466 2-s2.0-35548972917 (Pubitemid 350001896)
125. Zhang Z., Lin H., Shi M., Xu R., Fu J., Lv J., Chen L., Lv S., Li Y., Yu S., Geng H., Jin L., Lau G. K., Wang F. S., Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology 2012 27 supplement 2 112 120 10.1111/j.1440-1746.2011.07024.x
126. Peng L., Xie D. Y., Lin B. L., Liu J., Zhu H. P., Xie C., Zheng Y. B., Gao Z. L., Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011 54 3 820 828 10.1002/hep.24434
127. Ali G., Mohsin S., Khan M., Nasir G. A., Shams S., Khan S. N., Riazuddin S., Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis. Journal of Translational Medicine 2012 10 75 10.1186/1479-5876-10-75
128. Cho J. W., Lee C. Y., Ko Y., Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues. Journal of Gastroenterology and Hepatology 2012 27 8 1362 1370 10.1111/j.1440-1746.2012.07137.x
129. Alfarano C., Roubeix C., Chaaya R., Ceccaldi C., Calise D., Mias C., Cussac D., Bascands J. L., Parini A., Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell transplantation 2012 21 9 2009 2019 10.3727/096368912X640448
130. Morigi M., Imberti B., Zoja C., Corna D., Tomasoni S., Abbate M., Rottoli D., Angioletti S., Benigni A., Perico N., Alison M., Remuzzi G., Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. Journal of the American Society of Nephrology 2004 15 7 1794 1804 2-s2.0-3042628474 10.1097/01.ASN.0000128974.07460.34 (Pubitemid 38822058)
131. Herrera M. B., Bussolati B., Bruno S., Morando L., Mauriello-Romanazzi G., Sanavio F., Stamenkovic I., Biancone L., Camussi G., Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International 2007 72 4 430 441 2-s2.0-34547763362 10.1038/sj.ki.5002334 (Pubitemid 47237610)
132. Zoja C., Garcia P. B., Rota C., Conti S., Gagliardini E., Corna D., Zanchi C., Bigini P., Benigni A., Remuzzi G., Morigi M., Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. American Journal of Physiology 2012 303 9 F1370 F1381 10.1152/ajprenal.00057.2012
133. Yen T. H., Alison M. R., Cook H. T., Jeffery R., Otto W. R., Wright N. A., Poulsom R., The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment. Cell Proliferation 2007 40 2 143 156 2-s2.0-33947099485 10.1111/j.1365-2184. 2007.00423.x (Pubitemid 46398812)
134. Wise A. F., Ricardo S. D., Mesenchymal stem cells in kidney inflammation and repair. Nephrology 2012 17 1 10.1111/j.1440-1797.2011.01501.x
135. Humphreys B. D., Bonventre J. V., Mesenchymal stem cells in acute kidney injury. Annual Review of Medicine 2008 59 311 325 2-s2.0-39649113771 10.1146/annurev.med.59.061506.154239 (Pubitemid 351287940)
136. Tang H. L., Wang Z. G., Li Q., Ran H. T., Zheng Y. Y., Ren J. L., Ling Z. Y., Li A., Zhao B., Targeted delivery of bone mesenchymal stem cells by ultrasound destruction of microbubbles promotes kidney recovery in acute kidney injury. Ultrasound in Medicine and Biology 2012 38 4 661 669 10.1016/j.ultrasmedbio.2012.01.003
137. El Ansary M., Saadi G., Abd El-Hamid S. M., Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney function. Nephrology 2012 17 7 650 657 10.1111/j.1440-1797.2012.01622.x
138. Griffin M., Iqbal S. A., Bayat A., Exploring the application of mesenchymal stem cells in bone repair and regeneration. Journal of Bone and Joint Surgery B 2011 93 4 427 434 2-s2.0-79953831201 10.1302/0301-620X.93B4. 25249
139. Bruder S. P., Kurth A. A., Shea M., Hayes W. C., Jaiswal N., Kadiyala S., Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. Journal of Orthopaedic Research 1998 16 2 155 162 2-s2.0-0032029899 10.1002/jor.1100160202 (Pubitemid 28249153)
140. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S. M., Mukhachev V., Lavroukov A., Kon E., Marcacci M., Repair of large bone defects with the use of autologous bone marrow stromal cells. The New England Journal of Medicine 2001 344 5 385 386 2-s2.0-0035253558 10.1056/NEJM200102013440516 (Pubitemid 32107654)
141. Marcacci M., Kon E., Moukhachev V., Lavroukov A., Kutepov S., Quarto R., Mastrogiacomo M., Cancedda R., Stem cells associated with macroporous bioceramics for long bone repair: 6- To 7-year outcome of a pilot clinical study. Tissue Engineering 2007 13 5 947 955 2-s2.0-34249889868 10.1089/ten.2006.0271 (Pubitemid 46870419)
142. Kitoh H., Kitakoji T., Tsuchiya H., Mitsuyama H., Nakamura H., Katoh M., Ishiguro N., Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 2004 35 4 892 898 2-s2.0-5344274555 10.1016/j.bone.2004.06.013 (Pubitemid 39349220)
143. Kawate K., Yajima H., Ohgushi H., Kotobuki N., Sugimoto K., Ohmura T., Kobata Y., Shigematsu K., Kawamura K., Tamai K., Takakura Y., Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with β -tricalcium phosphate ceramics and free vascularized fibula. Artificial Organs 2006 30 12 960 962 2-s2.0-33845480596 10.1111/j.1525-1594.2006.00333.x (Pubitemid 44915585)
144. Gan Y., Dai K., Zhang P., Tang T., Zhu Z., Lu J., The clinical use of enriched bone marrow stem cells combined with porous β -tricalcium phosphate in posterior spinal fusion. Biomaterials 2008 29 29 3973 3982 2-s2.0-48349148436 10.1016/j.biomaterials.2008.06.026
145. Kitaori T., Ito H., Schwarz E. M., Tsutsumi R., Yoshitomi H., Oishi S., Nakano M., Fujii N., Nagasawa T., Nakamura T., Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis and Rheumatism 2009 60 3 813 823 2-s2.0-61649090805 10.1002/art.24330
146. Hernigou P., Poignard A., Beaujean F., Rouard H., Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. Journal of Bone and Joint Surgery A 2005 87 7 1430 1437 2-s2.0-21444445838 10.2106/JBJS.D.02215 (Pubitemid 40917741)
147. Pereira R. F., O'Hara M. D., Laptev A. V., Halford K. W., Pollard M. D., Class R., Simon D., Livezey K., Prockop D. J., Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proceedings of the National Academy of Sciences of the United States of America 1998 95 3 1142 1147 2-s2.0-0032477883 10.1073/pnas.95.3.1142 (Pubitemid 28124926)
148. Panaroni C., Gioia R., Lupi A., Besio R., Goldstein S. A., Kreider J., Leikin S., Vera J. C., Mertz E. L., Perilli E., Baruffaldi F., Villa I., Farina A., Casasco M., Cetta G., Rossi A., Frattini A., Marini J. C., Vezzoni P., Forlino A., In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009 114 2 459 468 2-s2.0-67651091674 10.1182/blood-2008-12-195859
149. Horwitz E. M., Prockop D. J., Fitzpatrick L. A., Koo W. W. K., Gordon P. L., Neel M., Sussman M., Orchard P., Marx J. C., Pyeritz R. E., Brenner M. K., Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Medicine 1999 5 3 309 313 2-s2.0-0032976690 10.1038/6529 (Pubitemid 29124367)
150. Horwitz E. M., Prockop D. J., Gordon P. L., Koo W. W. K., Fitzpatrick L. A., Neel M. D., McCarville M. E., Orchard P. J., Pyeritz R. E., Brenner M. K., Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001 97 5 1227 1231 2-s2.0-0035283077 10.1182/blood.V97.5.1227 (Pubitemid 32183743)
151. Horwitz E. M., Gordon P. L., Koo W. K. K., Marx J. C., Neel M. D., McNall R. Y., Muul L., Hofmann T., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8932 8937 2-s2.0-0037173116 10.1073/pnas.132252399 (Pubitemid 34693661)
152. Le Blanc K., Götherström C., Ringdén O., Hassan M., McMahon R., Horwitz E., Anneren G., Axelsson O., Nunn J., Ewald U., Nordén-Lindeberg S., Jansson M., Dalton A., Åström E., Westgren M., Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005 79 11 1607 1614 2-s2.0-20544455396 10.1097/01.TP. 0000159029.48678.93 (Pubitemid 40847594)
153. Whyte M. P., Kurtzberg J., McAlister W. H., Mumm S., Podgornik M. N., Coburn S. P., Ryan L. M., Miller C. R., Gottesman G. S., Smith A. K., Douville J., Waters-Pick B., Armstrong R. D., Martin P. L., Marrow cell transplantation for infantile hypophosphatasia. Journal of Bone and Mineral Research 2003 18 4 624 636 2-s2.0-0041805439 (Pubitemid 36899312)
154. Uccelli A., Moretta L., Pistoia V., Mesenchymal stem cells in health and disease. Nature Reviews Immunology 2008 8 9 726 736 2-s2.0-50249158511 10.1038/nri2395
155. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W., Ringdén O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. The Lancet 2008 371 9624 1579 1586 2-s2.0-43049103438 10.1016/S0140-6736(08)60690-X (Pubitemid 351626841)
156. Kebriaei P., Isola L., Bahceci E., Holland K., Rowley S., McGuirk J., Devetten M., Jansen J., Herzig R., Schuster M., Monroy R., Uberti J., Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 2009 15 7 804 811 2-s2.0-67149093649 10.1016/j.bbmt.2008.03.012
157. Duijvestein M., Vos A. C., Roelofs H., Wildenberg M. E., Wendrich B. B., Verspaget H. W., Kooy-Winkelaar E. M., Koning F., Zwaginga J. J., Fidder H. H., Verhaar A. P., Fibbe W. E., van den Brink G. R., Hommes D. W., Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010 59 12 1662 1669 10.1136/gut.2010.215152
158. Dalal J., Gandy K., Domen J., Role of mesenchymal stem cell therapy in Crohn's disease. Pediatric Research 2012 71 445 451 10.1038/pr.2011.56
159. Bai L., Lennon D. P., Eaton V., Maier K., Caplan A. I., Miller S. D., Miller R. H., Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009 57 11 1192 1203 2-s2.0-65649113921 10.1002/glia.20841
160. Constantin G., Marconi S., Rossi B., Angiari S., Calderan L., Anghileri E., Gini B., Bach S. D., Martinello M., Bifari F., Galiè M., Turano E., Budui S., Sbarbati A., Krampera M., Bonetti B., Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009 27 10 2624 2635 2-s2.0-70350212973 10.1002/stem.194
161. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., Uccelli A., Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Annals of Neurology 2007 61 3 219 227 2-s2.0-34147126415 10.1002/ana.21076 (Pubitemid 46557346)
162. Gordon D., Pavlovska G., Glover C. P., Uney J. B., Wraith D., Scolding N. J., Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neuroscience Letters 2008 448 1 71 73 2-s2.0-55549121533 10.1016/j.neulet.2008.10.040
163. Rafei M., Campeau P. M., Aguilar-Mahecha A., Buchanan M., Williams P., Birman E., Yuan S., Young Y. K., Boivin M. N., Forner K., Basik M., Galipeau J., Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. Journal of Immunology 2009 182 10 5994 6002 2-s2.0-70349881103 10.4049/jimmunol.0803962
164. Zhang J., Li Y., Chen J., Cui Y., Lu M., Elias S. B., Mitchell J. B., Hammill L., Vanguri P., Chopp M., Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Experimental Neurology 2005 195 1 16 26 2-s2.0-23644458723 10.1016/j.expneurol.2005.03.018 (Pubitemid 41116810)
165. Kassis I., Grigoriadis N., Gowda-Kurkalli B., Mizrachi-Kol R., Ben-Hur T., Slavin S., Abramsky O., Karussis D., Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Archives of Neurology 2008 65 6 753 761 2-s2.0-45149103232 10.1001/archneur.65.6.753 (Pubitemid 351831453)
166. Zhang J., Li Y., Lu M., Cui Y., Chen J., Noffsinger L., Elias S. B., Chopp M., Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. Journal of Neuroscience Research 2006 84 3 587 595 2-s2.0-33746862992 10.1002/jnr.20962 (Pubitemid 44196699)
167. Bonab M. M., Sahraian M. A., Aghsaie A., Karvigh S. A., Hosseinian S. M., Nikbin B., Lotfi J., Khorramnia S., Motamed M. R., Togha M., Harirchian M. H., Moghadam N. B., Alikhani K., Yadegari S., Jafarian S., Gheini M. R., Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Current stem cell research & therapy 2012 7 6 407 414
168. Yamout B., Hourani R., Salti H., Barada W., El-Hajj T., Al-Kutoubi A., Herlopian A., Baz E. K., Mahfouz R., Khalil-Hamdan R., Kreidieh N. M. A., El-Sabban M., Bazarbachi A., Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. Journal of Neuroimmunology 2010 227 1-2 185 189 2-s2.0-77956651196 10.1016/j.jneuroim.2010.07.013
169. Rowland L. P., Shneider N. A., Amyotrophic lateral sclerosis. The New England Journal of Medicine 2001 344 22 1688 1700 2-s2.0-0035978743 10.1056/NEJM200105313442207 (Pubitemid 32479968)
170. Karussis D., Kassis I., Kurkalli B. G. S., Slavin S., Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. Journal of the Neurological Sciences 2008 265 1-2 131 135 2-s2.0-38049086826 10.1016/j.jns.2007.05.005
171. Freedman M. S., Bar-Or A., Atkins H. L., Karussis D., Frassoni F., Lazarus H., Scolding N., Slavin S., Le Blanc K., Uccelli A., The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the international MSCT study group. Multiple Sclerosis 2010 16 4 503 510 2-s2.0-77951926479 10.1177/1352458509359727
172. Mazzini L., Ferrero I., Luparello V., Rustichelli D., Gunetti M., Mareschi K., Testa L., Stecco A., Tarletti R., Miglioretti M., Fava E., Nasuelli N., Cisari C., Massara M., Vercelli R., Oggioni G. D., Carriero A., Cantello R., Monaco F., Fagioli F., Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Experimental Neurology 2010 223 1 229 237 2-s2.0-77950858200 10.1016/j.expneurol.2009.08.007
173. Augello A., Tasso R., Negrini S. M., Cancedda R., Pennesi G., Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis and Rheumatism 2007 56 4 1175 1186 2-s2.0-34247231682 10.1002/art.22511 (Pubitemid 46608642)
174. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noël D., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis and Rheumatism 2005 52 5 1595 1603 2-s2.0-18644370435 10.1002/art.21012 (Pubitemid 40663952)
175. Dai L. J., Moniri M. R., Zeng Z. R., Zhou J. X., Rayat J., Warnock G. L., Potential implications of mesenchymal stem cells in cancer therapy. Cancer Letters 2011 305 1 8 20 2-s2.0-79953187914 10.1016/j.canlet.2011.02.012
176. Bao Q., Zhao Y., Niess H., Conrad C., Schwarz B., Jauch K. W., Huss R., Nelson P. J., Bruns C. J., Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells and Development 2012 21 13 2355 2363 10.1089/scd.2012.0060
177. Bexell D., Scheding S., Bengzon J., Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Molecular Therapy 2010 18 6 1067 1075 2-s2.0-77953133974 10.1038/mt.2010.58
178. Hu Y. L., Fu Y. H., Tabata Y., Gao J. Q., Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. Journal of Controlled Release 2010 147 2 154 162 2-s2.0-77957016314 10.1016/j.jconrel.2010. 05.015
179. Choi S. A., Hwang S. K., Wang K. C., Cho B. K., Phi J. H., Lee J. Y., Jung H. W., Lee D. H., Kim S. K., Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro-Oncology 2011 13 1 61 69 2-s2.0-79951602634 10.1093/neuonc/noq147
180. Loebinger M. R., Eddaoudi A., Davies D., Janes S. M., Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Research 2009 69 10 4134 4142 2-s2.0-66249083525 10.1158/0008-5472.CAN-08-4698
181. Sasportas L. S., Kasmieh R., Wakimoto H., Hingtgen S., Van De Water J. A. J. M., Mohapatra G., Figueiredo J. L., Martuza R. L., Weissleder R., Shah K., Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proceedings of the National Academy of Sciences of the United States of America 2009 106 12 4822 4827 2-s2.0-63849148548 10.1073/pnas.0806647106
182. Studeny M., Marini F. C., Champlin R. E., Zompetta C., Fidler I. J., Andreeff M., Bone marrow-derived mesenchymal stem cells as vehicles for interferon- β delivery into tumors. Cancer Research 2002 62 13 3603 3608 2-s2.0-0036644833 (Pubitemid 34728832)
183. Xin H., Kanehira M., Mizuguchi H., Hayakawa T., Kikuchi T., Nukiwa T., Saijo Y., Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 2007 25 7 1618 1626 2-s2.0-34547167177 10.1634/stemcells.2006-0461 (Pubitemid 47121838)